Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
The inhibitory activity associated with myelin is a major obstacle for successful axon regeneration in the adult mammalian central nervous system (CNS). In addition to myelin-associated glycoprotein (MAG) and Nogo-A, available evidence suggests the existence of additional inhibitors in CNS myelin. We show here that a glycosylphosphatidylinositol (GPI)-anchored CNS myelin protein, oligodendrocyte-myelin glycoprotein (OMgp), is a potent inhibitor of neurite outgrowth in cultured neurons. Like Nogo-A, OMgp contributes significantly to the inhibitory activity associated with CNS myelin. To further elucidate the mechanisms that mediate this inhibitory activity of OMgp, we screened an expression library and identified the Nogo receptor (NgR) as a high-affinity OMgp-binding protein. Cleavage of NgR and other GPI-linked proteins from the cell surface renders axons of dorsal root ganglia insensitive to OMgp. Introduction of exogenous NgR confers OMgp responsiveness to otherwise insensitive neurons. Thus, OMgp is an important inhibitor of neurite outgrowth that acts through NgR and its associated receptor complex. Interfering with the OMgp/NgR pathway may allow lesioned axons to regenerate after injury in vivo.
Wang
Kevin C
KC
Division of Neuroscience, Children's Hospital and Program in Neuroscience, Harvard Medical School, 320 Longwood Avenue, Boston, Massachusetts 02115, USA.
Koprivica
Vuk
V
Kim
Jieun A
JA
Sivasankaran
Rajeev
R
Guo
Yong
Y
Neve
Rachel L
RL
He
Zhigang
Z
D000818:Animals; D019556:COS Cells; D002417:Cattle; D002455:Cell Division; D048429:Cell Size; D002478:Cells, Cultured; D002490:Central Nervous System / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002642:Chick Embryo; D058851:GPI-Linked Proteins; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D017261:Glycosylphosphatidylinositols / Q000378:metabolism; D020439:Growth Cones / Q000378:metabolism; D006801:Humans; D008024:Ligands; D051379:Mice; D009185:Myelin Proteins; D009186:Myelin Sheath / Q000378:metabolism; D018992:Myelin-Associated Glycoprotein / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D063308:Myelin-Oligodendrocyte Glycoprotein; D009416:Nerve Regeneration; D016501:Neurites / Q000187:drug effects / Q000378:metabolism*; D000070816:Nogo Receptor 1; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D011233:Precipitin Tests; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism*; D012160:Retina / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism
D058851:GPI-Linked Proteins; D017261:Glycosylphosphatidylinositols; D008024:Ligands; C571326:MOG protein, human; C571327:Mog protein, mouse; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein; D000070816:Nogo Receptor 1; C560528:OMG protein, human; C560529:Omg protein, mouse; C486580:RTN4R protein, human; D011956:Receptors, Cell Surface; C419790:Rtn4r protein, mouse; D010738:Type C Phospholipases; D043265:Phosphatidylinositol Diacylglycerol-Lyase